Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Trial of Voyager VI (VV1) in Combination With Cemiplimab in Select Solid Tumors
NCT04291105Phase 2Active, not recruiting
- Sponsor
- Vyriad
- Start
- Apr 2020
- Primary completion
- Oct 2026
- Countries
- 2
01
Overview
A Phase 2 trial of Voyager-V1 in melanoma, head and neck squamous cell carcinoma (HNSCC), colorectal cancer (CRC), sponsored by Vyriad. Started Apr 2020; status: active, not recruiting.
02
Drugs
Voyager-V1
03
Conditions
melanomahead and neck squamous cell carcinoma (HNSCC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04291105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04291105.